Switching to bictegravir/emtricitabine/tenofovir alafenamide in adults aged > 65 years or older: Week 72 results from an international, phase IIIb, open-label trial
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要